Chromosome 22q a frequent site of allele loss in head and neck carcinoma

Head and Neck

Volumn 22, Issue 6, 2000, Pages 585-590

  Poli Frederico, Regina C ^a   Bergamo, Nadia A ^a   Reis, Patricia P ^a   Kowalski, Luiz P ^b   Zielenska, Maria ^c   Squire, Jeremy A ^d   Rogatto, Silvia R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Chromosome 22; Head and neck carcinomas; Loss of heterozygosity; Microsatellites

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 22Q; CHROMOSOME MAP; CLINICAL ARTICLE; GENE LOCUS; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LARYNX TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0033840539     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200009)22:6<585::AID-HED7>3.0.CO;2-4     Document Type: Article

References (37)

1. Allelic loss at chromosomes 3p, 8p, 13p and 17p associated with poor prognosis in head and neck cancer
2. Microsatellite alterations as clonal markers for the detection of human cancer
3. Sequential loss of heterozygosity at microsatellite motifs in pre-invasive and invasive head and neck squamous carcinoma
4. An allelotype of squamous carcinoma of the head and neck using microsatellite markers
5. Allelotype of head and neck squamous cell carcinoma
6. Head and neck cancer
7. Deletions on chromosome 22 in sporadic meningioma
8. Deletion mapping of the long arm of chromosome 22 in human meningiomas
9. The neurofibromatosis-type 2 gene is inactivated in schwannomas
10. Deletion mapping of chromosome 1p and 22q in pheochromocytoma
11. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
12. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers
13. Localization of an ovarian-cancer tumor-suppressor gene to a 0.5 cM region between D22S284 and CYP2D, on chromosome 22q
14. Narrowing the critical region for a rhabdoid tumor locus in 22q11
15. Genomic alterations in human breast carcinomas
16. Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas
17. Allelic loss on chromosome 22 in oral cancer: Possibility of the existence of a tumor suppressor gene on 22q13
18. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis-type-2 gene in central-nervous-system-tumors
19. Somatic mutations in the neurofibromatosis-type-2 gene in sporadic meningiomas
20. Molecular genetic investigation of the neurofibromatosis-type-2 tumor suppressor gene in sporadic meningioma
21. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas
22. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12
23. Suppressor gene and of chromosome 22 deletions in gliomas
24. Loss of heterozygosity on chromosome 22 in human gliomas does not inactive the neurofibromatosis-type-2 gene
25. Cytogenetic investigation in oral squamous cell carcinomas
26. Cytogenetic analysis of 11 squamous cell carcinomas of the head and neck
27. Cytogenetic analysis of head and neck carcinomas
28. Karyotypic features of malignant tumors of the nasal cavity and paranasal sinuses
29. Chromosome abnormalities in eight-three head and neck squamous cell carcinomas: Influence of culture conditions on karyotypic pattern
30. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma
31. Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas
32. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas
33. Genomic alterations associated with malignancy in head and neck cancer
34. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhab-doid tumors
35. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer